What Care Do I Need After a Stem Cell Transplant?

A stem cell transplant can be a lifesaving treatment for patients with leukemia, lymphoma, multiple myeloma, or certain blood-related disorders. In many cases, however, transplants increase patients’ risk for an array of long-term health problems, often caused by the high doses of chemotherapy and/or radiation therapy used prior to the transplant. Dana-Farber’s Adult Stem Cell Survivorship … Read more

Battling Cancer: Restructuring and Enjoying Your New Life

By Rich Rothman In September 2013, I had a bone marrow transplant that doctors advised was the only potential cure for a blood cancer known as MDS (myelodysplastic syndrome). Although we lived in New York City, we chose to have the transplant done at Dana Farber because we were impressed with everything we saw and … Read more

Pregnant with Non-Hodgkin Lymphoma, This Mom Found Care and Comfort at Dana-Farber

Elizabeth Larcom has six children, but it’s the youngest that she calls her “miracle baby” – and with good reason. In August 1997, the Army moved the Larcom family to Alaska with five kids under 12 and mom Elizabeth pregnant with the sixth. Soon after, husband and dad, Chuck, left for Army training in Louisiana. … Read more

He Lost His Sight to Cancer, But Not His Vision of a Full Life

When Tim Conners collected his wish from the Make-A-Wish Foundation in 2012 at the age of 18, he was blind from childhood leukemia that had spread to his optic nerve. A football player and wrestler who’d never been an outdoorsman, he asked to meet Erik Weihenmayer, the first blind person to climb the Seven Summits … Read more

The Latest Advances Against Hematologic Cancers

Treatment of blood-related, or hematologic, cancers is seizing on insights into the basic genetic wiring of cancer cells and the body’s system for finding and attacking those cells. Research presentations at the annual American Society of Hematology (ASH) meeting in December gave evidence of how broad, and rapid, the progress is. Targeted therapies, new combinations … Read more

Doctor and Nurse Team Up for Blood Cancers Support Group

By Ronni Gordon When my year of isolation ended after a stem cell transplant at Dana-Farber/Brigham and Women’s Cancer Center in 2003, I looked for a blood cancer support group near my home in western Massachusetts. I found support groups for just about everyone except patients like me with acute myeloid leukemia (AML) and other … Read more

Q&A with Young Adult Cancer Survivor Andrew McMahon

Andrew McMahon, founder of Dear Jack Foundation and front man of the band Andrew McMahon in the Wilderness, was diagnosed with leukemia at 22, in the midst of his musical career. Like other young adults with cancer, McMahon’s treatment affected every aspect of his life, from career to relationships and everything in between. Learn more … Read more

Voices Podcast – Season 2 Episode #2: Then and Now with Leukemia Survivor Ben Blaisdell

Ben Blaisdell was a popular 16-year-old when he started experiencing uncharacteristic chills, which led to an anemia diagnosis and, soon after, the surprising news that he had acute lymphoblastic leukemia (ALL). The two-year treatment was tough on him and his entire family, but Blaisdell says that he wouldn’t change his cancer diagnosis even if he … Read more

Feeling Lucky in an Unlucky Situation

By all accounts, Annie McNamara was living a typical young adult’s life in 2015. The 26-year-old lived in South Boston with a good friend from college, worked in Duxbury in the retail department of Island Creek Oysters, and liked spending time with her friends and boyfriend, Dan. She wasn’t a huge fan of the gym … Read more

New Immunotherapy Therapy Approved for Lymphoma Patients

The Food and Drug Administration (FDA) approved a new kind of immunotherapy drug for adults and children with classical Hodgkin lymphoma who have relapsed after three or more prior lines of therapy. The approved drug, pembrolizumab (Keytruda), is part of a class of immunotherapy drugs called checkpoint inhibitors that block the PD-1 protein, which is … Read more

Lymphoma Patient Gets Back on the Court Post-Treatment

For much of his 17 years, Spencer Riley has lived to play basketball. This winter, his favorite sport helped the teenager get back to life. Riley was diagnosed with non-Hodgkin lymphoma in 2016 and treated at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center that summer. He underwent an intensive three-month treatment cycle: one week of … Read more

Voices Podcast – Season 2 Episode #1: Then and Now with Lymphoma and Breast Cancer Survivor Catherine Goff

When Catherine Goff was diagnosed with Hodgkin lymphoma while attending college in the 1970s, it was the shock of a lifetime. Less surprising – but still life-changing – was her later diagnosis with breast cancer, a common secondary cancer for patients like Goff who received high doses of radiation therapy to the chest. Between these … Read more

Making the Best of Things In The Hospital

By Rich Rothman In 2013, I was facing a lengthy hospital stay after being diagnosed with a life-threatening blood cancer known as myelodysplastic syndromes (”MDS”). I had decided to proceed with a bone marrow transplant, which was thought to be the only potential cure. After being admitted to the hospital, I had intensive, round-the-clock chemotherapy … Read more

Putting College – and Field Hockey – on Hold for a Bone Marrow Transplant

By Dana Mendes Like many high school students, I was eager to start a new chapter of my life after graduating in 2015. I had committed to play field hockey at Assumption College in Worcester, Massachusetts, that fall, and spent the summer working out alongside my new teammates – determined to prove myself on the … Read more

What Are Adult Histiocyte Disorders?

Adult histiocyte disorders are a group of rare diseases that involve an over-production of white blood cells known as histiocytes, which destroy foreign substances and protect the body from infection. In adults, Langerhans cell histiocytosis (LCH) is the most common of these diseases. LCH arises when specialized histiocytes called dendritic cells become too abundant in … Read more